ModivCare Securities Class Action Lawsuit
Analysis based on 9 articles · First reported Feb 14, 2025 · Last updated Feb 24, 2025
The securities class action lawsuit against ModivCare is expected to negatively impact ModivCare's stock price and investor confidence due to allegations of misleading statements and insufficient liquidity. This event highlights potential risks for investors in companies with similar business models.
A securities class action lawsuit has been filed against ModivCare by Kessler Topaz Meltzer & Check on behalf of investors who purchased ModivCare securities between November 3, 2022, and September 15, 2024. The complaint alleges that ModivCare made materially false and/or misleading statements and failed to disclose adverse facts regarding its non-emergency medical transportation contracts, which negatively impacted its free cash flow and adjusted EBITDA, and that the company had insufficient liquidity. The lawsuit was filed in the United States — United States District Court for the District of Colorado, with a lead plaintiff deadline of March 31, 2025.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard